We next assessed the expression of COX4 in thyroid cancer cell lines that derived from FTCs (FTC133, FTC236 and FTC238), PTC (BCPAP), and MTC (TT). This evidence concerns the gene COX4I2 and medullary thyroid gland carcinoma.